Natural Ozempic? 6 GLP-1 Foods That Work Just Like the Shot
US Health Agency Unveils Weight-loss Drug Coverage Model
The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for weight-loss and diabetes under Medicaid and Medicare… Reuters Health Information
Healthcare, Vol. 14, Pages 51: Translational Lifestyle Medicine Approaches to Cardiovascular–Kidney–Metabolic Syndrome
Healthcare, Vol. 14, Pages 51: Translational Lifestyle Medicine Approaches to Cardiovascular–Kidney–Metabolic Syndrome Healthcare doi: 10.3390/healthcare14010051 Authors: Zacharias Papadakis Cardiovascular–Kidney–Metabolic (CKM) syndrome arises from interrelated cardiovascular, renal, and metabolic pathways that require coordinated therapeutic strategies. This narrative review synthesizes recent systematic reviews, meta-analyses, and original studies to evaluate the translational application of lifestyle medicine (LM) for […]
European markets close mixed; Novo Nordisk shares jump 9%, extending rally after GLP-1 pill approval – CNBC
European markets close mixed; Novo Nordisk shares jump 9%, extending rally after GLP-1 pill approval CNBC European shares close at fresh record high as Novo Nordisk drives healthcare boost Reuters European market rebound led by pharma gains; STOXX 600 logs new record high (EUR:USD) Seeking Alpha Stock market today, December 23: Novo Nordisk’s promotion dominates Europe. Fincantieri rebounds […]
NVO’s First Oral Obesity Pill Approval: What Does it Mean for Lilly?
Earlier this week, the FDA approved Eli Lilly and Company’s LLY rival Novo Nordisk’s NVO oral version of the obesity drug Wegovy (semaglutide). Wegovy is the first oral GLP-1 drug to be approved in the United States, ushering in a new era of obesity treatment. The Wegovy pill includes the same active ingredient — semaglutide — contained […]
Incretin Therapies After Bariatric Surgery Linked to Lower Risk of Alcohol Disorder
(MedPage Today) — Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation of medications for AUD compared…
The Wegovy weight loss pill could come to Canada. What we know
The FDA approved the one-a-day Wegovy pill, the first oral GLP-1 medication for obesity in the U.S., Wegovy manufacturer Novo Nordisk said in a statement Tuesday.
PFE’s Oncology & Obesity Pipeline Position It for Post-LOE Growth
Pfizer PFE expects a significant negative impact on revenues from the loss of exclusivity (“LOE”) of several of its key products in the 2026-2030 period. These include Eliquis, Vyndaqel, Ibrance, Xeljanz and Xtandi, all of which face patent expirations. However, the company has strengthened its R&D pipeline through M&A deals, successful data readouts and pivotal program […]
New species are being discovered faster than ever before
New species are now being discovered faster than ever before, a new study suggests. About 300 years ago, Swedish naturalist Carl Linnaeus set out on a bold quest: to identify and name every living organism on Earth. Now celebrated as the father of modern taxonomy, he developed the binomial naming system and described more than […]
Two New Developments May Help Future Plaintiffs Compel GLP-1 Coverage
Two recent developments may potentially increase GLP-1 coverage for more patients with obesity. The lack of coverage may be another failure of recognizing obesity as a chronic disease. Medscape Diabetes & Endocrinology